Chauhan Daksh, Punchak Maria, Gutbrod Joseph, Moorthy Gyan, Thach Bethany, Rosseau Gail
Perelman School of Medicine, University of Pennsylvania, Philadelphia , Pennsylvania , USA.
Department of Neurosurgery, University of Pennsylvania Health System, Philadelphia , Pennsylvania , USA.
Neurosurgery. 2024 Nov 1;95(5):963-975. doi: 10.1227/neu.0000000000002996. Epub 2024 Jun 5.
Neural tube defects (NTDs) are an important cause of global morbidity worldwide. Well-planned global neurosurgery and public health efforts can aid vulnerable communities, but there is a need to elucidate the global burden of NTDs and identify regions without available data to better target interventions.
A scoping review to quantify worldwide NTD prevalence using the PubMed/Medline and birth defects surveillance registries was conducted. Data published after January 1, 1990, encompassing prevalence values of at least the 2 most prevalent NTDs-spina bifida and encephalocele-were abstracted. Average NTD prevalence rates were aggregated by World Health Organization (WHO) region and World Bank classification, and differences were determined using the analysis of variance test. Differences in availability of nationally representative data by WHO region and World Bank classification were determined using χ 2 tests.
This review captured 140 studies from a total of 93 of 194 WHO member countries. The percentage of countries within a geographic region with available NTD prevalence data was highest in the Eastern Mediterranean (EMR) (85.7%) and lowest in Africa (AFR) (31.3%). The NTD prevalence range was 0.9-269.6 per 10 000 births. Statistically significant differences in reported NTD prevalence rates existed by WHO Region ( P = .00027) and World Bank income level of study country ( P = .00193). Forty countries (43%) had conducted national-level studies assessing NTD prevalence. There was a statistically significant difference in the availability of nationally representative prevalence data depending on the WHO region ( P = .0081) and World Bank classification of study country ( P = .0017).
There is a gap in availability of NTD prevalence data worldwide, with many WHO member states lacking national-level NTD prevalence estimates. These findings highlight the need for greater NTD surveillance efforts to identify the countries with the greatest need for targeted global intervention.
神经管缺陷(NTDs)是全球发病的一个重要原因。精心规划的全球神经外科手术和公共卫生努力可以帮助脆弱社区,但有必要阐明NTDs的全球负担,并确定缺乏可用数据的地区,以便更好地确定干预目标。
利用PubMed/Medline和出生缺陷监测登记处进行了一项范围综述,以量化全球NTDs患病率。提取1990年1月1日之后发表的数据,这些数据至少涵盖2种最常见的NTDs——脊柱裂和脑膨出的患病率值。按世界卫生组织(WHO)区域和世界银行分类汇总平均NTDs患病率,并使用方差分析检验确定差异。使用χ2检验确定WHO区域和世界银行分类的全国代表性数据可用性的差异。
本综述涵盖了来自194个WHO成员国中93个国家的140项研究。有NTDs患病率数据的地理区域内国家的百分比在东地中海地区(EMR)最高(85.7%),在非洲(AFR)最低(31.3%)。NTDs患病率范围为每10000例出生0.9 - 269.6例。WHO区域(P = .00027)和研究国家的世界银行收入水平(P = .00193)报告的NTDs患病率存在统计学显著差异。40个国家(43%)进行了评估NTDs患病率的国家级研究。根据WHO区域(P = .0081)和研究国家的世界银行分类(P = .0017),全国代表性患病率数据的可用性存在统计学显著差异。
全球NTDs患病率数据的可用性存在差距,许多WHO成员国缺乏国家级NTDs患病率估计。这些发现凸显了加大NTDs监测力度的必要性,以确定最需要针对性全球干预的国家。